COMMUNIQUÉS West-GlobeNewswire

Invuity Announces 2017 Fourth Quarter, Full Year Financial Results and Conference Call Date

31/01/2018 - 14:00

SAN FRANCISCO, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ: IVTY ), a leading medical technology company focused on minimal access surgery, today announced that it will release its 2017 fourth quarter and [...]

Filament Biosolutions Partners with Leading Canadian Academic Centers for $9.1M Project to Study Precision Nutritional Therapies for Inflammatory Bowel Disease

31/01/2018 - 14:00

NEW YORK, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Filament BioSolutions, Inc., a company focused on the development and commercialization of clinical nutrition therapeutics announced a collaboration with the University of [...]

Richard Hill, MD, PhD, is Elected to the American Health Council’s Board of Physicians

31/01/2018 - 14:00

NEW YORK, Jan. 31, 2018 (GLOBE NEWSWIRE) -- The American Health Council is honored to elect Richard R. Hill, MD, PhD, to its Board of Physicians. With over 20 years of experience in adult pharmacotherapy, psychotherapy [...]

SeaSpine Expands Ventura™ NanoMetalene® Implant Offering to Accommodate Larger Range of Posterior Procedures

31/01/2018 - 14:00

CARLSBAD, Calif., Jan. 31, 2018 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE ), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced [...]

Kalytera Announces Grant of Stock Options

31/01/2018 - 14:00

SAN FRANCISCO and TEL AVIV, Israel, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE:KALY) (OTCQB:KALTF) (the " Company " or " Kalytera ") today announced that it has granted stock options on [...]

Stealth Mark Conducts Exploratory Meetings for its ActiveDuty Technology with Homeland Security

31/01/2018 - 14:00

HOFFMAN ESTATES, IL, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Wellness Center USA, Inc. (OTCQB: WCUI ), today announced that its wholly-owned subsidiary, StealthCo, Inc., dba Stealth Mark, at the request of Homeland Security [...]

Maple Leaf Anticipates the Completion of Its Telkwa, B.C. Facility in Early Summer 2018

31/01/2018 - 14:00

CALGARY, Alberta, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“ Maple Leaf ” or the “ Company ”) (TSX-V: MGW ) (OTCQB:MGWFF) is pleased to announce that it has received a timetable schedule from the [...]

Beleave Receives Notification of Pre-Sale Inspection Date

31/01/2018 - 13:35

TORONTO, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Beleave Inc. (" Beleave " or the " Company ") (CSE:BE)(OTCQX:BLEVF) is pleased to announce that it has received notification from Health Canada that the Company's pre-sale [...]

Oncolix Sponsors Additional Research with MD Anderson Cancer Center

31/01/2018 - 13:30

HOUSTON, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Oncolix, Inc., (OTCQB:ONCX) announced today that the Company has sponsored additional research with MD Anderson Cancer Center. The research will evaluate Prolanta TM for the [...]

KemPharm to Present at The MoneyShow Orlando Investor Conference

31/01/2018 - 13:30

CORALVILLE, Iowa, Jan. 31, 2018 (GLOBE NEWSWIRE) -- KemPharm, Inc. (Nasdaq: KMPH ), a clinical-stage specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, announced today [...]

GTX Corp Silver Sponsor at Super Bowl LII Big Game Experience Showcasing New Line of Biometric Insoles at Gifting Suite

31/01/2018 - 13:30

LOS ANGELES, Jan. 31, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB: GTXO ) , an Internet of Things (IoT) solutions provider in the personal location, wearable and wandering assistive technology business, announced today [...]

Innovate Biopharmaceuticals Announces Trading Under New Ticker Symbol INNT is Anticipated to Begin on Thursday, February 1, 2018

31/01/2018 - 13:30

RALEIGH, N.C., Jan. 31, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (NASDAQ: INNT ), a clinical stage biotechnology company focused on developing novel autoimmune and inflammation therapeutics, announced [...]

Protalix BioTherapeutics’ pegunigalsidase alfa Receives Fast Track Designation from the U.S. Food and Drug Administration

31/01/2018 - 13:30

CARMIEL, Israel, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE: PLX ), announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to [...]

ESPERITE (ESP) and BGI Genomics (BGI) sign a strategic agreement to offer Whole Genome Sequencing on a large scale.

31/01/2018 - 13:26

Esperite with BGI sequencing technology will enable the global population easier access to the gold standard in clinical genetic testing. Amsterdam, The Netherlands - 31 January 2018 BGI is the world's genome sequencing [...]

Published Study Demonstrates the Association Between Immunovaccine’s Proprietary Immune-targeted Delivery Technology and Enhanced Efficacy in Slowing Tumor Progression

31/01/2018 - 13:05

HALIFAX, Nova Scotia, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX: IMV ) (OTCQX:IMMVF), a clinical stage immuno-oncology company, today announced the publication of a preclinical study using magnetic [...]

Allergy Therapeutics: Trading Update

31/01/2018 - 13:00

Allergy Therapeutics plc ("Allergy Therapeutics" or the "Group") Trading Update Market share gains driving top line growth Strong cash position sustained by good performance. 31 January 2017 Allergy Therapeutics plc ( [...]

Microbot Medical Inc. to Initiate Townhall Meetings

31/01/2018 - 13:00

HINGHAM, Mass., Jan. 31, 2018 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT ), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today [...]

Cara Therapeutics Initiates Pivotal Phase 3 Efficacy Trial of KORSUVA™ (CR845/difelikefalin) Injection in Hemodialysis Patients with Chronic Kidney Disease-Associated Pruritus

31/01/2018 - 13:00

STAMFORD, Conn., Jan. 31, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA ), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus and [...]

Revive Therapeutics Submits Cannabinoid Delivery Technology Findings Abstract for 29th International Conference on Polyphenols and the 9th Tannin Conference

31/01/2018 - 13:00

TORONTO, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (" Revive " or the " Company ") (TSX VENTURE:RVV) (OTCQB:RVVTF), a company focused on the research, development and commercialization of novel [...]